Bion Therapeutics (India) Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2005.
2005 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Bion Therapeutics (India) Private Limited

Bion Therapeutics (India) Private Limited, a active private limited company, was established on 05 September 2005 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2005PTC047358. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.

It upholds a compliant status. Employing 172 professional, Its leadership includes Sudesh Raj Mathur (Director), Beerelli Satyam (Director), Giridhara Rao Mungi (Director). Past directors included Sneha Vijaykumar Kangoni, Venkata Sita Rama Ravi Kumar Chilukuri, Suman Achyut Naik. It holds ₹7.06 Cr open charges and ₹8.85 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 303, H.No.5-10-194, Chakrapani Estate, Opp, Control Room, Saifabad, Hyderabad, Telangana, 500004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2005PTC047358

  • Registration Number

    047358

  • Incorporation Date

    05 September 2005

  • Authorized Capital

    ₹0.60 M

  • Paid-Up Capital

    ₹0.60 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.60 M
  • Paid Up Capital ₹ 0.60 M
  • Company Age 20 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.06 Cr
  • Satisfied Charges ₹ 8.85 Cr
  • Revenue Growth **** 44.86%
  • Profit Growth **** 8.49%
  • Ebitda **** 41.94%
  • Net Worth 51.24%
  • Total Assets **** 139.36%
Company report

Bion Therapeutics (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bion Therapeutics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bion Therapeutics (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudesh Raj Mathur Director 05 Sep 2005 Current
Beerelli Satyam Director 05 Sep 2005 Current
Giridhara Rao Mungi Director 09 Nov 2015 Current
Amitav Rout Director 26 Jul 2019 Current
Laxman Prasad Managing Director 05 Sep 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 May 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 21 May 2011 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 26 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bion Therapeutics (India).

Bion Therapeutics (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.86% increase. The company also saw a slight improvement in profitability, with a 8.49% increase in profit. The company's net worth Soared by an impressive increase of 51.24%.

Bion Therapeutics (India) revenue growth over time
Bion Therapeutics (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 44.86%
*******
*******
*******
*******
Revenue from Operations
*******
 44.85%
*******
*******
*******
*******
Total Assets
*******
 139.36%
*******
*******
*******
*******
Profit or Loss
*******
 8.49%
*******
*******
*******
*******
Net Worth
*******
 51.24%
*******
*******
*******
*******
EBITDA
*******
 41.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bion Therapeutics (India)?

In 2022, Bion Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹70,600,000.00

Satisfied Charges

₹88,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 7.06 Cr
Latest Charge Details
Date Lender Amount Status
21 Oct 2023 Axis Bank Limited ₹3.00 M Open
19 Jul 2023 Axis Bank Limited ₹6.76 Cr Open
25 Jul 2023 Others ₹1.00 Cr Satisfied
31 Dec 2021 Indian Overseas Bank ₹6.10 Cr Satisfied
27 Oct 2020 Standard Chartered Bank ₹7.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bion Therapeutics (India)?

Bion Therapeutics (India) has a workforce of 172 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bion Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bion Therapeutics (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bion Therapeutics (India)
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 25 Jul 2023 via Charge ID 100761171 with Others was fully satisfied on 13 Jan 2026. was completed.

  • Annual General Meeting

    Progress on Bion Therapeutics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Bion Therapeutics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 3.00 M with Charge ID 100853146 was registered on 21 Oct 2023. was recorded as a recent event.

  • Charges

    The activity A charge registered on 31 Dec 2021 via Charge ID 100537496 with Indian Overseas Bank was fully satisfied on 02 Aug 2023. was completed.

  • Charges

    A charge with Others amounted to Rs. 10.00 M with Charge ID 100761171 was registered on 25 Jul 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bion Therapeutics (India) Private Limited?

The CIN of Bion Therapeutics (India) Private Limited is U24239TG2005PTC047358.

Where is Bion Therapeutics (India) Private Limited headquartered?

Bion Therapeutics (India) Private Limited is headquartered at 303, H.No.5-10-194, Chakrapani Estate, Opp, Control Room, Saifabad, Hyderabad, Telangana, 500004.

When was Bion Therapeutics (India) Private Limited incorporated?

Bion Therapeutics (India) Private Limited was incorporated on 05 September 2005.

Who are the current directors of Bion Therapeutics (India) Private Limited?

The current directors of Bion Therapeutics (India) Private Limited are

What is the primary industry of Bion Therapeutics (India) Private Limited?

The primary industry of Bion Therapeutics (India) Private Limited is Manufacturing.

Is Bion Therapeutics (India) Private Limited a listed company?

Bion Therapeutics (India) Private Limited is unlisted.

What is the capital structure of Bion Therapeutics (India) Private Limited?

The authorized capital of Bion Therapeutics (India) Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.

What is the compliance status of Bion Therapeutics (India) Private Limited?

The compliance status of Bion Therapeutics (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available